John Stoddard Cancer Center is a cancer care center located in Central Iowa. It was the first cancer center in that location. The John Stoddard Cancer Center is a part of Iowa Health-Des Moines, where a number of important treatment options and services originated.

During the past decade, John Stoddard Cancer Center at Iowa Methodist Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 79 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 11 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John Stoddard Cancer Center at Iowa Methodist Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 84 trials, followed by "Eastern Cooperative Oncology Group" with 21 trials sponsored, "Children's Oncology Group" with 14 trials sponsored, "SWOG Cancer Research Network" with 12 trials sponsored and "Radiation Therapy Oncology Group" with 12 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Stoddard Cancer Center at Iowa Methodist Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 154 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Eastern Cooperative Oncology Group" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "John Stoddard Cancer Center at Iowa Methodist Medical Center" are "Breast Cancer" (33 trials), "Lung Cancer" (23 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (13 trials), "Lymphoma" (12 trials) and "Leukemia" (11 trials). Many other conditions were trialed in "John Stoddard Cancer Center at Iowa Methodist Medical Center" in a lesser frequency.

Most popular intervention types in "John Stoddard Cancer Center at Iowa Methodist Medical Center" are "Drug" (127 trials), "Biological" (55 trials), "Other" (40 trials), "Radiation" (35 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (28 trials), "radiation therapy" (21 trials), "carboplatin" (20 trials), "cyclophosphamide" (17 trials) and "bevacizumab" (14 trials). Other intervention names were less common.

The vast majority of trials in "John Stoddard Cancer Center at Iowa Methodist Medical Center" are 131 trials for "All" genders, 21 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "John Stoddard Cancer Center at Iowa Methodist Medical Center". undefined are not yet recruiting, 1 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 136 completed trials in John Stoddard Cancer Center at Iowa Methodist Medical Center, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in John Stoddard Cancer Center at Iowa Methodist Medical Center, 7 "Phase 1" clinical trials were conducted, 68 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".